NP94023a-d Ellipta Inhalers
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
28 Jul 2023
Description
Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro® Ellipta®) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse® Ellipta®) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Trelegy® Ellipta®)
Scope
- Reference
- ocds-h6vhtk-03eb16
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—